ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,132, issued on Dec. 2, was assigned to Rubedo Life Sciences Inc. (Sunnyvale, Calif.).
"GPX4 inhibitors and senolytic compounds and uses thereof" was invented by Michael Hadd (San Jose, Calif.) and Paul Keitz (Redwood City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds that kill senescent cells i.e., senolytic compounds and compounds which inhibit GPX4. The present invention also provides compounds and methods for treating senescence-associated diseases or disorders, and compounds and methods for treating diseases or disorders impacted by GPX4."
The patent was filed on June 24, 2025, under Applicatio...